IN2015DN02685A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02685A
IN2015DN02685A IN2685DEN2015A IN2015DN02685A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A IN 2685DEN2015 A IN2685DEN2015 A IN 2685DEN2015A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A
Authority
IN
India
Prior art keywords
subject
cancer
radiation
predisposition
copd
Prior art date
Application number
Other languages
English (en)
Inventor
Diana; Anderson
Mojgan; Jafzadeh
Morgan Clive Thomas; Denyer
Original Assignee
Univ Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bradford filed Critical Univ Bradford
Publication of IN2015DN02685A publication Critical patent/IN2015DN02685A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7004—Stress
    • G01N2800/7009—Oxidative stress
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN2685DEN2015 2012-09-11 2013-09-10 IN2015DN02685A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1216174.1A GB201216174D0 (en) 2012-09-11 2012-09-11 Method of determining a predisposition to disease states characterised by free redical induced dna damage
PCT/GB2013/052365 WO2014041340A1 (en) 2012-09-11 2013-09-10 Methods of, and assay products for, determining the predisposition of a subject to disease states characterised by free radical induced dna damage

Publications (1)

Publication Number Publication Date
IN2015DN02685A true IN2015DN02685A (enExample) 2015-09-04

Family

ID=47137246

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2685DEN2015 IN2015DN02685A (enExample) 2012-09-11 2013-09-10

Country Status (7)

Country Link
US (1) US20150219619A1 (enExample)
EP (1) EP2895853A1 (enExample)
JP (1) JP2015529077A (enExample)
CN (1) CN104755927A (enExample)
GB (1) GB201216174D0 (enExample)
IN (1) IN2015DN02685A (enExample)
WO (1) WO2014041340A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9931634B2 (en) 2014-02-27 2018-04-03 The Regents Of The Univeristy Of California High throughput DNA damage quantification of human tissue with home-based collection device
EP4006527B1 (en) * 2019-07-25 2025-07-16 Seoul Viosys Co., Ltd Light irradiation apparatus comprising led and method of using the same
US20230383362A1 (en) 2020-10-22 2023-11-30 4D Lifetec Ag Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007103116A2 (en) * 2006-03-02 2007-09-13 Laboratory Corporation Of America Holdings Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair

Also Published As

Publication number Publication date
JP2015529077A (ja) 2015-10-05
CN104755927A (zh) 2015-07-01
EP2895853A1 (en) 2015-07-22
WO2014041340A1 (en) 2014-03-20
US20150219619A1 (en) 2015-08-06
GB201216174D0 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
HK1219763A1 (zh) 用於癌症预後的组合物和方法
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
WO2014028378A3 (en) Methods and systems for detecting biological components
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
CL2013003433A1 (es) Método para analizar una muestra biológica de un sujeto con cáncer que comprende determinar un nivel de expresión de los biomarcadores gli-1, otx-2, shroom2, pdlim3, y sphk1 en dicha muestra, en donde el nivel de expresión de los biomarcadores en coparación con un control, proporciona un indicador de diagnóstico de si el sujeto tiene una probabilidad aumentada de respuesta a: un ácido metil-4’-trifluorometoxi-bifenil-3-carboxílixo [6-(cis-2,6-dimetil-morfolino-4-il)-piridin-3-il]-amida, ó 2-[(r)-4-(6-bencil-4,5-dimetil-piridazin-3-il)-2-metil-3,4,5,6-tetrahidro-2h-[1,2’] bipirizanil-5’-il]-propan-2-ol; método para seleccionar a un sujeto que tiene cáncer para el tratamiento con uno de dichos compuestos, el cual comprende determinar el nivel de expresión de shroom2 o sphk1, en una muestra biológica del sujeto.
ZA201603872B (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
EP4321866A3 (en) Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
MY182773A (en) Method for indicating a presence or non-presence of aggressive prostate cancer
WO2013172779A3 (en) Method for indicating the presence or non-presence of prostate cancer
BR112013006683A2 (pt) diagnóstico de câncer de mama
HK1199099A1 (en) Methods and compositions for the treatment and diagnosis of cancer
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
WO2011112845A3 (en) Methods and compositions related to a multi-methylation assay to predict patient outcome
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
NZ701527A (en) Diagnostic gene marker panel for colorectal cancer
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
WO2013124738A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer
HK1209673A1 (en) Using modulators of ccr5 for treating cancer
WO2013170057A3 (en) Quantification of lipoproteins
WO2015077342A3 (en) Detection of arginine methylation of egfr for prediction of resistance to therapy
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.
AU2012371260A8 (en) Predicitive biomarker for cancer treatment with ADCC enhanced antibodies
MX2015004419A (es) Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables.